These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 28337976)
21. Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: A possible mechanistic basis for its anticancer activity. Ashraf SM; Mahanty S; Rathinasamy K Life Sci; 2021 Dec; 287():120105. PubMed ID: 34756929 [TBL] [Abstract][Full Text] [Related]
22. Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy. Best RL; LaPointe NE; Azarenko O; Miller H; Genualdi C; Chih S; Shen BQ; Jordan MA; Wilson L; Feinstein SC; Stagg NJ Toxicol Appl Pharmacol; 2021 Jun; 421():115534. PubMed ID: 33852878 [TBL] [Abstract][Full Text] [Related]
23. Curcumin suppresses the dynamic instability of microtubules, activates the mitotic checkpoint and induces apoptosis in MCF-7 cells. Banerjee M; Singh P; Panda D FEBS J; 2010 Aug; 277(16):3437-48. PubMed ID: 20646066 [TBL] [Abstract][Full Text] [Related]
24. Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity. Magalhaes LG; Marques FB; da Fonseca MB; Rogério KR; Graebin CS; Andricopulo AD PLoS One; 2016; 11(8):e0160842. PubMed ID: 27508497 [TBL] [Abstract][Full Text] [Related]
25. 2-(Naphthalene-1-yl)-6-pyrrolidinyl-4-quinazolinone inhibits skin cancer M21 cell proliferation through aberrant expression of microtubules and the cell cycle. Wu YC; Hour MJ; Leung WC; Wu CY; Liu WZ; Chang YH; Lee HZ J Pharmacol Exp Ther; 2011 Sep; 338(3):942-51. PubMed ID: 21652781 [TBL] [Abstract][Full Text] [Related]
26. Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells. Das Mukherjee D; Kumar NM; Tantak MP; Das A; Ganguli A; Datta S; Kumar D; Chakrabarti G Biochemistry; 2016 May; 55(21):3020-35. PubMed ID: 27110637 [TBL] [Abstract][Full Text] [Related]
27. Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery. Lu PH; Kung FL; Kuo SC; Chueh SC; Guh JH Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):223-33. PubMed ID: 17102938 [TBL] [Abstract][Full Text] [Related]
28. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents. Tangutur AD; Kumar D; Krishna KV; Kantevari S Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738 [TBL] [Abstract][Full Text] [Related]
29. [Progress in the study of tubulin inhibitors]. Shang H; Pan L; Yang S; Chen H; Cheng MS Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562 [TBL] [Abstract][Full Text] [Related]
30. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin. Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098 [TBL] [Abstract][Full Text] [Related]
31. Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane. Azarenko O; Okouneva T; Singletary KW; Jordan MA; Wilson L Carcinogenesis; 2008 Dec; 29(12):2360-8. PubMed ID: 18952594 [TBL] [Abstract][Full Text] [Related]
32. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation. Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625 [TBL] [Abstract][Full Text] [Related]
33. Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells. Mukhtar E; Adhami VM; Sechi M; Mukhtar H Cancer Lett; 2015 Oct; 367(2):173-83. PubMed ID: 26235140 [TBL] [Abstract][Full Text] [Related]
34. Cytotoxic activity and cytostatic mechanism of novel 2-arylbenzo[b]furans. Yang H; Pang JY; Cai YC; Xu ZL; Xian LJ J Pharm Pharmacol; 2006 Sep; 58(9):1281-7. PubMed ID: 16945188 [TBL] [Abstract][Full Text] [Related]
35. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity. Acharya BR; Choudhury D; Das A; Chakrabarti G Biochemistry; 2009 Jul; 48(29):6963-74. PubMed ID: 19527023 [TBL] [Abstract][Full Text] [Related]
36. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells. Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070 [TBL] [Abstract][Full Text] [Related]
37. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin. Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307 [TBL] [Abstract][Full Text] [Related]
38. Thalidomide (5HPP-33) suppresses microtubule dynamics and depolymerizes the microtubule network by binding at the vinblastine binding site on tubulin. Rashid A; Kuppa A; Kunwar A; Panda D Biochemistry; 2015 Mar; 54(12):2149-59. PubMed ID: 25747795 [TBL] [Abstract][Full Text] [Related]
39. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis. de Arruda M; Cocchiaro CA; Nelson CM; Grinnell CM; Janssen B; Haupt A; Barlozzari T Cancer Res; 1995 Jul; 55(14):3085-92. PubMed ID: 7606731 [TBL] [Abstract][Full Text] [Related]
40. Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells. Hage-Sleiman R; Herveau S; Matera EL; Laurier JF; Dumontet C BMC Cancer; 2010 Apr; 10():135. PubMed ID: 20384997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]